MetaCap

Oaktree Acquisition III Life Sciences (OACC) vs Vernal Capital Acquisition (VECA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Oaktree Acquisition III Life Sciences is the larger company by market cap ($141.9 million vs $129.8 million), about 1.1 times the size. On valuation, Oaktree Acquisition III Life Sciences trades at a lower trailing P/E (59.5x vs 144.3x for Vernal Capital Acquisition).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OACC+0.19%VECA+1.92%
+2%+1%-1%
May 19, 20261 yearNov 18, 2026
OACC+0.09%VECA+2.02%
+2%+1%-1%
May 18, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OACC versus VECA key metrics
MetricOACCVECA
Share price$10.71$10.10
Market cap$141.93M$129.80M
1-day change-0.19%0.00%
YTD return+1.23%—
1-year return+1.42%—
P/E ratio (TTM)59.50144.29
EPS (TTM)$0.18$0.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$7.29M—
52-week high$10.93$11.01
52-week low$10.50$9.87
Distance from 52-week high-2.01%-8.27%
Average volume28.11K26.32K
Shares outstanding13.25M12.85M
SectorFinanceFinance
IndustryBlank ChecksBlank Checks

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Vernal Capital Acquisition trades at a higher earnings multiple (144.3x vs 59.5x trailing P/E).

About Oaktree Acquisition III Life Sciences

OACC stock →

Oaktree Acquisition Corp. III Life Sciences does not have significant operations.

Finance · Blank Checks

About Vernal Capital Acquisition

VECA stock →

Vernal Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

Finance · Blank Checks

OACC vs VECA FAQ

Which is bigger, Oaktree Acquisition III Life Sciences or Vernal Capital Acquisition?

Oaktree Acquisition III Life Sciences (OACC) is larger, with a market capitalization of $141.93M compared with $129.80M for Vernal Capital Acquisition (VECA).

Which has the lower P/E ratio, OACC or VECA?

OACC has the lower trailing P/E at 59.5, versus 144.3 for VECA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Oaktree Acquisition III Life Sciences and Vernal Capital Acquisition in the same industry?

Yes. Both are classified in the Blank Checks industry within the Finance sector.

More comparisons